Secukinumab-induced subacute cutaneous lupus erythematosus

Dermatol Ther. 2020 May;33(3):e13417. doi: 10.1111/dth.13417. Epub 2020 May 3.

Affiliations

¹ Dermatology and Venereology Department, University of Trieste, Ospedale Maggiore di Trieste, Italy.
² Department of Clinical and Experimental Medicine, Dermatology, University of Messina, Messina, Italy.
³ Unit of Allergology, Immunology, Rheumatology, Department of Medicine, University of Campus Bio-Medico of Rome, Rome, Italy.
⁴ Department of Medical, Surgical Sciences and Health, Eye Clinic, University of Trieste, Trieste, Italy.

PMID: 32291870
DOI: 10.1111/dth.13417

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized*
Humans
Lupus Erythematosus, Cutaneous* / chemically induced
Lupus Erythematosus, Cutaneous* / diagnosis
Lupus Erythematosus, Cutaneous* / drug therapy

Substances

Antibodies, Monoclonal, Humanized
secukinumab